Flatiron Health

Cancer-specific electronic health record platform

New York City, New York, United States

About Flatiron Health

Flatiron Health focuses on improving cancer care and research through its specialized platform. The company provides a cancer-specific Electronic Health Record (EHR) system that helps healthcare providers manage patient information efficiently while enhancing the patient experience. This system integrates real-world data in real-time, allowing for smarter research and better patient outcomes. Flatiron connects various stakeholders in the cancer care ecosystem, such as community oncologists and academic researchers, facilitating collaboration and data sharing to accelerate cancer research and improve care quality. Unlike its competitors, Flatiron generates revenue through subscriptions for its EHR system and partnerships with life sciences companies, providing access to valuable real-world data for research and treatment development. The company's goal is to leverage data quality and patient care to transform oncology, making it a significant player in the healthcare sector.

New York City, New YorkHeadquarters
2012Year Founded
$304.6MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Work/life autonomy via flexible work hours and flexible paid time off
Generous parental leave (16 weeks for either parent)
Transition back to work program following parental leave
Child and caregiver travel benefits for new parents
Backup child care
Weekly meditation sessions
Flatiron-sponsored fitness classes
Weekly massages and manicures available onsite (employee funded)

Risks

Over-reliance on partnerships like Willowglade could pose risks if partnerships fail.
Integration challenges with new technologies may lead to operational inefficiencies.
Intensifying competition in oncology healthtech could erode Flatiron's market share.

Differentiation

Flatiron Health integrates real-world data to enhance cancer care and research.
The company partners with top oncology companies and academic centers for data-driven insights.
Flatiron's OncoEMR platform offers a cancer-specific EHR system for improved patient management.

Upsides

Partnership with Willowglade enhances patient experience through a unified digital platform.
Collaboration with Tempus integrates genomic testing into OncoEMR, expanding diagnostic capabilities.
Flatiron's Clinical Pipe streamlines data capture, increasing clinical trial participation.